121 related articles for article (PubMed ID: 2122652)
1. The beneficial effect of chronic lisuride administration compared with levodopa in Parkinson's disease.
Rabey JM; Streifler M; Treves T; Korczyn AD
Adv Neurol; 1990; 53():451-5. PubMed ID: 2122652
[No Abstract] [Full Text] [Related]
2. Clinical experience with duodenal infusions of levodopa for the treatment of motor fluctuations in Parkinson's disease.
Sage JI; Sonsalla PK; McHale DM; Heikkila RE; Duvoisin RC
Adv Neurol; 1990; 53():383-6. PubMed ID: 2122646
[No Abstract] [Full Text] [Related]
3. Comparison between L-dopa and lisuride intravenous infusions: a clinical study.
Ruggieri S; Stocchi F; Carta A; Bravi D; Bragoni M; Giorgi L; Agnoli A
Mov Disord; 1988; 3(4):313-9. PubMed ID: 3211176
[TBL] [Abstract][Full Text] [Related]
4. Fluctuations in plasma levodopa and motor responses with liquid and tablet levodopa/carbidopa.
Metman LV; Hoff J; Mouradian MM; Chase TN
Mov Disord; 1994 Jul; 9(4):463-5. PubMed ID: 7969216
[TBL] [Abstract][Full Text] [Related]
5. Concurrent administration of donepezil HCl and levodopa/carbidopa in patients with Parkinson's disease: assessment of pharmacokinetic changes and safety following multiple oral doses.
Okereke CS; Kirby L; Kumar D; Cullen EI; Pratt RD; Hahne WA
Br J Clin Pharmacol; 2004 Nov; 58 Suppl 1(Suppl 1):41-9. PubMed ID: 15496222
[TBL] [Abstract][Full Text] [Related]
6. Apomorphine and lisuride infusion. A comparative chronic study.
Stocchi F; Bramante L; Monge A; Viselli F; Baronti F; Stefano E; Ruggieri S
Adv Neurol; 1993; 60():653-5. PubMed ID: 8420205
[No Abstract] [Full Text] [Related]
7. Ten years' experience with enteral levodopa infusions for motor fluctuations in Parkinson's disease.
Syed N; Murphy J; Zimmerman T; Mark MH; Sage JI
Mov Disord; 1998 Mar; 13(2):336-8. PubMed ID: 9539350
[TBL] [Abstract][Full Text] [Related]
8. Mood and anxiety fluctuation in Parkinson's disease associated with levodopa infusion: preliminary findings.
Maricle RA; Nutt JG; Carter JH
Mov Disord; 1995 May; 10(3):329-32. PubMed ID: 7651451
[TBL] [Abstract][Full Text] [Related]
9. Five-year follow-up of early lisuride and levodopa combination therapy versus levodopa monotherapy in de novo Parkinson's disease. The French Lisuride Study Group.
Allain H; Destée A; Petit H; Patay M; Schück S; Bentué-Ferrer D; Le Cavorzin P
Eur Neurol; 2000; 44(1):22-30. PubMed ID: 10894991
[TBL] [Abstract][Full Text] [Related]
10. Dopaminergic responsiveness to apomorphine after chronic treatment with subcutaneous lisuride infusion in Parkinson's disease.
Vaamonde J; Luquin MR; Obeso JA
Mov Disord; 1990; 5(3):260-2. PubMed ID: 2388647
[TBL] [Abstract][Full Text] [Related]
11. L-deprenyl, a MAO-B inhibitor, as an adjunct to conventional L-dopa therapy in Parkinson's disease: experience in 200 patients.
Elizan TS; Yahr MD; Moros DA; Mendoza MR; Pang S; Bodian CA
Adv Neurol; 1990; 53():431-5. PubMed ID: 2122649
[No Abstract] [Full Text] [Related]
12. [Usefulness of increasing the proportion of carbidopa to levodopa in the long-term treatment of Parkinson's disease].
Bermejo Pareja F; Martínez-Martín P
Med Clin (Barc); 1984 Feb; 82(7):305-10. PubMed ID: 6717135
[No Abstract] [Full Text] [Related]
13. Bromocriptine and lisuride in Parkinson's disease.
Caraceni T; Giovannini P; Parati E; Scigliano G; Grassi MP; Carella F
Adv Neurol; 1984; 40():531-5. PubMed ID: 6695632
[No Abstract] [Full Text] [Related]
14. Comparison of efficacy of lisuride hydrogen maleate with increased doses of levodopa in parkinsonian patients.
Rabey JM; Treves T; Streifler M; Korczyn AD
Adv Neurol; 1987; 45():569-72. PubMed ID: 3825734
[No Abstract] [Full Text] [Related]
15. [On-off phenomena in Parkinson's disease. Continuous dopaminergic stimulation].
Stocchi F; Ruggieri S; Baronti F; Bellantuono P; Brughita G; Antonini A; Bravi D; Agnoli A
Clin Ter; 1987 Jul; 122(2):83-8. PubMed ID: 2973904
[No Abstract] [Full Text] [Related]
16. Continuous subcutaneous apomorphine infusions for fluctuating Parkinson's disease. Long-term follow-up in 18 patients.
Poewe W; Kleedorfer B; Wagner M; Bösch S; Schelosky L
Adv Neurol; 1993; 60():656-9. PubMed ID: 8420206
[No Abstract] [Full Text] [Related]
17. Madopar HBS (hydrodynamically balanced system) in the treatment of Parkinson's disease.
Lees AJ
Adv Neurol; 1990; 53():475-82. PubMed ID: 2239487
[No Abstract] [Full Text] [Related]
18. Bromocriptine and levodopa in early combination in Parkinson's disease: first results of the Collaborative European Multicentric Trial.
Olsson JE
Adv Neurol; 1990; 53():421-3. PubMed ID: 2239483
[No Abstract] [Full Text] [Related]
19. [Oral lisuride in Parkinson's disease].
Obeso JA; Luquin MR; Martínez Lage JM
Med Clin (Barc); 1985 Sep; 85(8):307-12. PubMed ID: 4068822
[No Abstract] [Full Text] [Related]
20. Bromocriptine and lisuride in Parkinson disease.
Lieberman AN; Gopinathan G; Neophytides A; Leibowitz M; Walker R; Hiesiger E
Ann Neurol; 1983 Jan; 13(1):44-7. PubMed ID: 6830164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
